Eli Lilly | LLY

Stock Price
1,026.94
Daily Change
2.17 0.21%
Monthly
-5.00%
Yearly
18.72%
Q1 Forecast
1,025.69



Peers Price Chg Day Year Date
AbbVie 219.02 -3.42 -1.54% 14.17% Feb/11
Abbott 112.03 -0.25 -0.22% -14.77% Feb/11
ALKERMES 34.72 -0.12 -0.34% 8.64% Feb/10
Amgen 361.82 -2.83 -0.78% 21.96% Feb/11
AstraZeneca 14,628.00 464.00 3.28% 23.95% Feb/11
Baxter International 21.83 -0.11 -0.50% -27.93% Feb/11
Biogen 188.99 -4.82 -2.49% 35.58% Feb/10
Bristol-Myers Squibb 59.90 -0.96 -1.58% 6.68% Feb/11
Coherus Biosciences 2.11 0.05 2.43% 90.09% Feb/10
Gilead Sciences 152.64 5.41 3.67% 58.77% Feb/11

Indexes Price Day Year Date
US500 6975 33.66 0.48% 15.26% Feb/11

Eli Lilly traded at $1,024.77 this Tuesday February 10th, decreasing $19.90 or 1.90 percent since the previous trading session. Looking back, over the last four weeks, Eli Lilly lost 5.20 percent. Over the last 12 months, its price rose by 18.47 percent. Looking ahead, we forecast Eli Lilly to be priced at 1,025.69 by the end of this quarter and at 934.10 in one year, according to Trading Economics global macro models projections and analysts expectations.

Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.



News Stream
Eli Lilly Stock Price Hits 7-week Low
Eli Lilly shares decreased to 1004.00 USD, the lowest since December 2025. Over the past 4 weeks, Eli Lilly lost 3.5%, and in the last 12 months, it increased 21.67%.
2026-02-03
Eli Lilly Stock Price Hits 4-week Low
Eli Lilly shares decreased to 1032.00 USD, the lowest since December 2025. Over the past 4 weeks, Eli Lilly lost 2.65%, and in the last 12 months, it increased 38.47%.
2026-01-15
Eli Lilly Stock Price Hits 5-week High
Eli Lilly shares increased to 1090.00 USD, the highest since November 2025. Over the past 4 weeks, Eli Lilly gained 9.04%, and in the last 12 months, it increased 40.67%.
2026-01-07